Neurobiological, Harvard Medical School, Children's Hospital deal

The parties will collaborate to identify and develop neuroprotective compounds to treat central nervous system damage associated with brain surgery, traumatic brain injury and stroke, as well as chronic conditions such as dementia, neurodegenerative conditions and neuropathic pain. NTII will provide funding to Children's Hospital and receive an exclusive license to inventions in the neuroprotection field and an option to commercialize other products invented or developed within the two-year collaboration. ...